Cholangiocarcinoma

Displaying 1 - 8 of 8CSV
Jurkiewicz, M., Yeh, R., Shu, C. A., Hsiao, S. J., Mansukhani, M. M., Saqi, A., & Fernandes, H. (2025). Challenges in Amplicon-Based DNA NGS Identification of MET Exon 14 Skipping Events in Non-Small Cell Lung Cancers. Journal of Molecular Pathology, 6(1), 5. https://doi.org/10.3390/jmp6010005
Publication Date
Vujasinovic, M., Elbe, P., Ekheden, I., Wang, Q.-L., Thuresson, M., Roelstraete, B., Ghazi, S., Löhr, J.-M., & Ludvigsson, J. F. (2024). Gastrointestinal cancer precursor risk and mortality in pancreatic intraductal papillary mucinous neoplasms: a nationwide cohort study. Scandinavian Journal of Gastroenterology, 59(5), 600–607. https://doi.org/10.1080/00365521.2024.2310162
Publication Date
Chatila, W. K., Walch, H., Hechtman, J. F., Moyer, S. M., Sgambati, V., Faleck, D. M., Srivastava, A., Tang, L., Benhamida, J., Ismailgeci, D., Campos, C., Wu, F., Chang, Q., Vakiani, E., de Stanchina, E., Weiser, M. R., Widmar, M., Yantiss, R. K., Shah, M. A., … Yaeger, R. (2023). Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nature Communications, 14(1). https://doi.org/10.1038/s41467-022-35592-9
Publication Date
O’Connell, G. M., Aschen, S. Z., & Spector, J. A. (2023). SP49. Surgical Management of Advanced Squamous Cell Carcinoma of the Head and Neck in HPV+ Patients. Plastic and Reconstructive Surgery - Global Open, 11(5S), 150–150. https://doi.org/10.1097/01.gox.0000938540.30661.27
Publication Date
Aschen, S. Z., O’Connell, G. M., & Spector, J. A. (2023). D160. HPV-associated Survival and Surgical Management of Advanced Squamous Cell Carcinoma of the Head And Neck. Plastic and Reconstructive Surgery - Global Open, 11(4S), 136–137. https://doi.org/10.1097/01.gox.0000935208.34491.5f
Publication Date
Ingram, M. A., Lauren, B. N., Pumpalova, Y., Park, J., Lim, F., Bates, S. E., Kastrinos, F., Manji, G. A., Kong, C. Y., & Hur, C. (2022). Cost‐effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab‐paclitaxel in borderline resectable/locally advanced pancreatic cancer patients. Cancer Reports, 5(9). Portico. https://doi.org/10.1002/cnr2.1565
Publication Date
Tabrizian, P., Holzner, M. L., Mehta, N., Halazun, K., Agopian, V. G., Yao, F., Busuttil, R. W., Roberts, J., Emond, J. C., Samstein, B., Brown, R. S., Najjar, M., Chapman, W. C., Doyle, M. Mb., Florman, S. S., Schwartz, M. E., & Llovet, J. M. (2022). Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma. JAMA Surgery. https://doi.org/10.1001/jamasurg.2022.2800
Publication Date
Hassan, H., Vanessa, W., Zemla, T., Yin, J., Prasai, K., Abdellatief, A., Katta, R., Tran, N., & Mahipal, A. (2022). P-181 Outcomes of neoadjuvant and/or adjuvant treatment vs surgical resection alone for patients with cholangiocarcinoma: An inverse probability of treatment weighting with predictive nomogram. Annals of Oncology, 33, S314. https://doi.org/10.1016/j.annonc.2022.04.271
Publication Date